Platelets contain numerous growth factors and cytokines that can activate various signaling pathways in cells upon activation by exocytosis. They contain both pro-inflammatory (e.g., IL1β) and also anti-inflammatory cytokines (e.g., IL10). Two ends of a spectrum. Now, how the biological activity of platelets could be engineered/controlled during PRP?